India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
The Western U.S. commercial real estate sector is gearing up for a pivotal year in 2026, with new forecasts from Kidder Mathews showing steady economic growth, moderating inflation, and improving fundamentals across office, industrial, retail, and multifamily markets. From slow but stabilizing office recovery to strong retail performance and tightening industrial demand, the region is entering a period of rebalancing that presents fresh opportunities for real estate and related professionals.
A delayed federal jobs report has pushed ADP’s data into the spotlight, revealing that private employers added just 22,000 jobs in January — far below expectations. Revised December numbers and ongoing declines in key sectors like professional services and manufacturing point to a cooling labor market heading into 2025. While wage growth remains steady, uneven job creation across regions and industries is raising new questions about future interest‑rate cuts and what this shifting economy means for professionals in fields like real estate, mortgage, insurance, and finance.
Nashville’s booming tech-driven population is transforming luxury real estate, making smart technology and eco‑friendly design the new standard. From AI‑powered adaptive living and advanced security systems to high‑efficiency construction and green incentives, the city’s top communities—Brentwood, Franklin, and Nolensville—are leading a movement toward intelligent, energy‑saving homes that offer long‑term value and modern comfort.
Florida legislators have confirmed that no new insurance relief is coming in 2026, leaving homeowners to grapple with rising premiums and shrinking options. While Republican leaders argue that past reforms simply need more time to stabilize the market, Democrats are pushing for immediate action as families across the state feel the financial strain. With insurance changes off the table, lawmakers are shifting their focus to property tax relief—creating important ripple effects for real estate, mortgage, and insurance professionals watching the market closely.
A new CBRE survey reveals that 2026 is shaping up to be a bullish year for commercial real estate, with most investors planning to expand their portfolios. Dallas secures the top spot for the fifth year in a row, but Southeast metros like Atlanta, Miami, Tampa, and Charlotte are rapidly gaining ground thanks to population growth, strong job creation, and resilient demand in sectors like tech, logistics, and healthcare.
Washington State University’s Carson College of Business has introduced Carson Pro, a flexible online platform offering non‑credit certificates in finance, management, marketing, accounting, and specialty fields like the business of aging and wine business management. Designed for working professionals seeking practical, career-ready skills or a complete career reset, the program reflects a nationwide shift toward continuous learning as industries—from real estate to finance—evolve at a rapid pace.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
